Intracranial Hodgkin's disease is very rare and is often a terminal event. The case of a 33-year-old man who relapsed in the anterior pituitary gland without other evidence of disease 6 months after extended field radiation therapy for Stage IIA Hodgkin's disease is presented. He remains well with n
6.16. Genetic markers in patients with Hodgkin's disease
✍ Scribed by U. Sliwinski; P. Kühnl; P.S. Mitrou; W. Spielmann
- Book ID
- 113368989
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 172 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0379-0738
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Expression of interleukin‐6 (IL‐6) and IL‐6 receptors has been demonstrated in Hodgkin and Reed‐Sternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of IL‐6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56
Transglutaminase activity in monocytes and serum lysozyme level were tested in 40 patients with Hodgkin's disease and were found to be significantly increased. Transglutaminase activity in monocytes from patients in a clinicaly active stage of the disease was higher than in clinically inactive cases